COOPER COMPANIES, INC. COO
Ophthalmic Goods · Nasdaq
Umsatz
$3.59B
+8.6% Jahresübergangsrate
Nettoerlös
$294.20M
-23.7% Jahresübergangsrate
Gesamtvermögen
$11.66B
+1.4% Jahresübergangsrate
EPS
1.48
-23.7% Jahresübergangsrate
Advertisement
Einkommensrechnung
| Zeitraum | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Revenues | $3.03B | $1.97B | $964.70M | $3.59B | $2.88B | $1.87B | $931.60M | $3.31B |
| Gross Profit | $2.03B | $1.34B | $660.20M | $2.36B | $1.92B | $1.25B | $623.80M | $2.14B |
| R&D Expense | $130.80M | $86.20M | $40.70M | $137.40M | $117.40M | $78.40M | $39.50M | $110.30M |
| SG&A Expense | $1.21B | $786.90M | $387.90M | $1.50B | $1.14B | $761.20M | $380.90M | $1.34B |
| Operating Income (Loss) | $542.50M | $366.80M | $182.00M | $533.10M | $507.30M | $314.80M | $153.10M | $507.60M |
| Interest Expense | — | — | — | — | — | — | — | — |
| Net Income (Loss) | $104.30M | $104.30M | $104.30M | $294.20M | $81.20M | $81.20M | $81.20M | $385.80M |
| EPS (Diluted) | 1.45 | 0.96 | 0.52 | 1.48 | 1.37 | 0.85 | 0.41 | 1.94 |
Bilanz
| Zeitraum | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.39B | $12.39B | $12.39B | $11.66B | $12.32B | $12.32B | $12.32B | $11.49B |
| Current Assets | $2.11B | $2.11B | $2.11B | $1.95B | $1.95B | $1.95B | $1.95B | $1.70B |
| Cash & Equivalents | $124.90M | $116.20M | $100.90M | $120.80M | $109.70M | $112.40M | $135.20M | $138.20M |
| Accounts Receivable | $829.00M | $829.00M | $829.00M | $717.00M | $717.00M | $717.00M | $717.00M | $609.70M |
| Inventory | $846.00M | $846.00M | $846.00M | $802.70M | $802.70M | $802.70M | $802.70M | $735.60M |
| PP&E (Net) | — | — | — | $1.86B | — | — | — | $1.63B |
| Goodwill | $3.85B | $3.85B | $3.85B | $3.84B | $3.84B | $3.84B | $3.84B | $3.62B |
| Total Liabilities | $4.16B | $4.16B | $4.16B | $4.23B | $4.23B | $4.23B | $4.23B | $4.11B |
| Current Liabilities | $1.11B | $1.11B | $1.11B | $1.02B | $1.02B | $1.02B | $1.02B | $969.00M |
| Accounts Payable | $300.40M | $300.40M | $300.40M | $260.50M | $260.50M | $260.50M | $260.50M | $261.90M |
| Stockholders Equity | $8.24B | $8.24B | $8.24B | $8.08B | $8.08B | $8.08B | $8.08B | $7.55B |
Kassenfluss
| Zeitraum | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 FY | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 FY |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $548.20M | $286.80M | $190.60M | $607.50M | $441.20M | $233.70M | $122.70M | $692.40M |
| Investing Cash Flow | $-274.10M | $-176.00M | $-96.80M | $-449.00M | $-523.00M | $-398.90M | $-324.10M | $-1.83B |
| Financing Cash Flow | $-261.50M | $-105.20M | $-96.60M | $-173.90M | $67.60M | $155.20M | $212.30M | $1.19B |
| Stock Repurchases | $93.30M | $40.60M | $0 | $0 | $0 | $0 | — | $78.50M |
Mehr erfahren
How to Find Any SEC Filing in Two MinutesCash-Flow Quality: Profit Is an Opinion, Cash Is a FactValuation Basics: P/E, P/S and What They Actually Tell YouDividends: How Companies Pay Shareholders and How to Read ThemHow to Read a 10-K Annual Report (Without Falling Asleep)Understanding Earnings Per Share (EPS)How to Read a Cash Flow StatementHow to Read a Balance SheetHow to Read an Income Statement
Daten stammen aus der öffentlichen Datenbank des US-amerikanischen SEC EDGAR. Diese Seite bietet keine Anlageberatung.